Recurrence of pseudomyxoma peritonei after cytoreduction and hyperthermic intraperitoneal chemotherapy: Location, treatment, and outcome

被引:0
|
作者
Smeenk, R [1 ]
Verwaal, VJ [1 ]
Zoetmulder, FA [1 ]
机构
[1] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:25 / 25
页数:1
相关论文
共 50 条
  • [1] Survival analysis of pseudomyxoma peritonei after cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy
    Smeenk, R.
    Verwaal, V.
    Zoetmulder, F.
    EJC SUPPLEMENTS, 2005, 3 (02): : 174 - 175
  • [2] Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Mercier, F.
    Dagbert, F.
    Pocard, M.
    Goere, D.
    Quenets, F.
    Wentert, R.
    Dumont, F.
    Brigand, C.
    Passot, G.
    Glehen, O.
    Abba, J.
    Abboud, K.
    Alyami, M.
    Arvieux, C.
    Averous, G.
    Bakrin, N.
    Balague, G.
    Barrau, V
    Ben Rejeb, H.
    Bereder, J-M
    Berton-Rigaud, I
    Bibeau, F.
    Bonnefoy, I
    Bouzard, D.
    Bricault, I
    Caramella, C.
    Carrere, S.
    de Chaisemartin, C.
    Chassang, M.
    Chevallier, A.
    Courvoisier, T.
    Dartigues, P.
    Dohan, A.
    Eveno, C.
    Faruch-Bilfeld, M.
    Ferron, G.
    Fontaine, J.
    Fournier, L.
    Gabiache, E.
    Gagniere, J.
    Geffroy, D.
    Ghouti, L.
    Gilly, F-N
    Gladieff, L.
    Guibal, A.
    Guilloit, J-M
    Guyon, F.
    Heyd, B.
    Hoeffel, C.
    Hordonneau, C.
    BJS OPEN, 2019, 3 (02): : 195 - 202
  • [3] POSTOPERATIVE CEA STATUS PREDICTS EARLY RECURRENCE AFTER COMPLETE CYTOREDUCTION AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR PSEUDOMYXOMA PERITONEI.
    Sato, Y.
    Gohda, Y.
    Matsunaga, R.
    Shuno, Y.
    Yano, H.
    DISEASES OF THE COLON & RECTUM, 2017, 60 (06) : E454 - E454
  • [4] Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei
    Witkamp, AJ
    de Bree, E
    Kaag, MM
    van Slooten, GW
    van Coevorden, F
    Zoetmulder, FAN
    BRITISH JOURNAL OF SURGERY, 2001, 88 (03) : 458 - 463
  • [5] Pseudomyxoma Peritonei Biological Features Are the Dominant Prognostic Determinants After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
    Baratti, Dario
    Kusamura, Shigeki
    Nonaka, Daisuke
    Cabras, Antonello Domenico
    Laterza, Barbara
    Deraco, Marcello
    ANNALS OF SURGERY, 2009, 249 (02) : 243 - 249
  • [6] Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery
    Scally, Christopher P.
    Fournier, Keith F.
    Mansfield, Paul F.
    JAMA SURGERY, 2021, 156 (03)
  • [7] Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin: A Single Center Experience
    Santullo, Francesco
    Pacelli, Fabio
    Abatini, Carlo
    Attalla El Halabieh, Miriam
    Fortunato, Giusy
    Lodoli, Claudio
    Giovinazzo, Francesco
    Rotolo, Stefano
    Di Giorgio, Andrea
    FRONTIERS IN SURGERY, 2021, 8
  • [8] Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei: outcome in 519 patients
    Taflampas, P.
    Dayal, S.
    Chandrakumaran, K.
    Mohamed, F.
    Moran, B.
    BRITISH JOURNAL OF SURGERY, 2013, 100 : 15 - 16
  • [9] Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei - a report of 103 procedures
    Smeenk, RM
    Verwaal, VJ
    Zoetmulder, FAN
    EJSO, 2006, 32 (02): : 186 - 190
  • [10] Pregnancy after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei
    Campanati, Renato Gomes
    Hanan, Bernardo
    de Souza, Sergio Simoes
    da Silva, Rodrigo Gomes
    CASE REPORTS IN SURGERY, 2014, 2014